Site-specific targeting in immunoliposomal nanomedicine for oncology: opportunities and limitations

Key Points

• Targeting strategies improve drug delivery in oncology, enhancing therapeutic outcomes while reducing side effects.
• Important metrics indicate that tumor localization increases effectiveness by up to 80% over conventional methods.
• Analysis on treatment regimens explores immunoliposomal applications in various cancer types and their unique targeting capabilities.
• Supports the need for further research to validate these approaches in clinical settings; external validation is essential.